SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-041197
Filing Date
2021-08-05
Accepted
2021-08-05 08:01:26
Documents
67
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ljpc-10q_20210630.htm   iXBRL 10-Q 1910294
2 EX-31.1 ljpc-ex311_6.htm EX-31.1 18445
3 EX-31.2 ljpc-ex312_7.htm EX-31.2 18392
4 EX-32.1 ljpc-ex321_8.htm EX-32.1 15871
5 GRAPHIC g4vfo5s522gp000001.jpg GRAPHIC 67979
  Complete submission text file 0001564590-21-041197.txt   6980465

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ljpc-20210630.xsd EX-101.SCH 56190
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ljpc-20210630_cal.xml EX-101.CAL 64267
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ljpc-20210630_def.xml EX-101.DEF 181033
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ljpc-20210630_lab.xml EX-101.LAB 419873
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ljpc-20210630_pre.xml EX-101.PRE 309799
11 EXTRACTED XBRL INSTANCE DOCUMENT ljpc-10q_20210630_htm.xml XML 1063587
Mailing Address 201 JONES ROAD, SUITE 400 WALTHAM MA 02451
Business Address 201 JONES ROAD, SUITE 400 WALTHAM MA 02451 617-715-3600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36282 | Film No.: 211146400
SIC: 2836 Biological Products, (No Diagnostic Substances)